Structures by: Lena G.
Total: 6
C12H15N3O2
C12H15N3O2
Chemical Communications (Cambridge, United Kingdom) (2006) 39 4069-4071
a=15.3543(11)Å b=15.3543(11)Å c=9.7571(17)Å
α=90° β=90° γ=120°
3(C21H23N3O3),0.759(H2O)
3(C21H23N3O3),0.759(H2O)
Chemical Communications (Cambridge, United Kingdom) (2006) 39 4069-4071
a=15.7533(3)Å b=10.5328(2)Å c=17.8744(5)Å
α=90° β=102.8050(1)° γ=90°
10-methyl-8,9,10,11,11a,12-hexahydro5H,7H-isoquinolino[3,2-g][1,3,5]triazepine- 7,11-dione
C13H15N3O2
Acta Crystallographica Section E (2006) 62, 2 o518-o520
a=12.1766(2)Å b=12.5948(2)Å c=15.4676(3)Å
α=90° β=90° γ=90°
Ethyl 4-hydroxymethyl-2-methylpyridine-5-carboxylate
C10H13NO3
Acta Crystallographica Section E (2008) 64, 5 o883
a=4.4998(2)Å b=15.4499(8)Å c=14.2036(7)Å
α=90.00° β=96.4170(10)° γ=90.00°
7-Isopropyl-5-methyl-1,3,5-triazepane-2,6-dione deuterated chloroform 0.94-solvate
C8H15N3O2,0.467(CDCl3),0.472(CDCl3)
Acta Crystallographica Section E (2007) 63, 5 o2306-o2308
a=11.8160(2)Å b=12.5893(3)Å c=18.3033(4)Å
α=90.00° β=90.00° γ=90.00°
C12H15N3O2
C12H15N3O2
Chemical Communications (Cambridge, United Kingdom) (2006) 39 4069-4071
a=15.583(2)Å b=15.583(2)Å c=9.964(1)Å
α=90° β=90° γ=120°